Abeona Therapeutics Inc (FRA:PCJ)
€ 5.9 0 (0%) Market Cap: 256.81 Mil Enterprise Value: 164.59 Mil PE Ratio: 0 PB Ratio: 3.64 GF Score: 42/100

Q2 2021 Abeona Therapeutics Inc Earnings Call Transcript

Jul 29, 2021 / 12:30PM GMT
Release Date Price: €7.5
Operator

Good day, and welcome to the Abeona Therapeutics Second Quarter 2021 Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded. I'll now introduce your host for today's conference, Greg Gin, Vice President of Investor Relations and Corporate Communications at Abeona. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Paul. Good morning, everyone. I would like to welcome and thank you for joining us on our second quarter 2021 conference call.

The press release announcing the second quarter results and recent operational progress is available on our website at www.abeonatherapeutics.com.

On the call today with prepared remarks are Michael Amoroso, Chief Executive Officer of Abeona; and Ed Carr, Chief Accounting Officer. After the prepared remarks, we will host the Q&A session. We are also joined by Dr. Vish Seshadri, Head of Research and Clinical Development; and Dr. Brian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot